Clinical Trial Update: Safety and Performance Evaluation of the Topical Hemostatic Device (AC5™) Following Excision of Skin Lesions [NA]

View source ↗

Summary

Completed clinical trial evaluating safety and performance of the AC5 topical hemostatic device after excision of skin lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Neoplasms

Drugs mentioned

• AC5™ topical hemostatic device (AC5 topical hemostatic device)

Snippet

Sponsor: Arch Therapeutics | Conditions: Skin Neoplasms | NA | Status: COMPLETED | Results posted: 2018-08-07